Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
RATIONALE: Diagnostic procedures using fludeoxyglucose F 18 and a surgical probe may help find lymph node metastases in patients with early-stage non-small cell lung cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 works in detecting lymph node metastasis in patients with stage I or stage II non-small cell lung cancer that can be removed by surgery.
Checked against the public recordLast updated Oct 18, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Roswell Park Cancer Institute
- Interventions being studied
- Drug: chemotherapy; Procedure: lymphadenectomy; Procedure: neoadjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery; Procedure: thoracic surgical procedure; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
DISEASE CHARACTERISTICS: * Diagnosis of non-small cell lung cancer * Stage I-II disease * Resectable disease * Planning to undergo surgical resection * No tumors that are not fludeoxyglucose F 18 (FDG)-avid on PET scan PATIENT CHARACTERISTICS: * Not pregnant * Negative pregnancy test * Fertile patients must use effective contraception * No previous allergic reaction to fludeoxyglucose F 18 * No contraindication to a pulmonary lobectomy and lymphadenectomy PRIOR CONCURRENT THERAPY: * See Disease Characteristics
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Roswell Park Cancer InstituteBuffalo, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 18, 2017. Always confirm current availability with the study team.